Cyclodextrin (CD) has been used to prepare biocompatible and nontoxic metal-organic frameworks (MOFs) suitable for biomedical applications as drug carriers. In this study, γ-CD/K-based MOF (γ-CD-MOF-1-α) was synthesized and its stability in various solvents was explored by single-crystal X-ray diffractometry (SCXRD) and powder X-ray diffractometry (PXRD). As a result of solvent-induced phase transformations, two novel crystalline phases of γ-CD-MOF-1 were discovered. The newly formed ε- and δ-phases crystallize in orthorhombic and tetragonal symmetry, respectively. In ε-phase, toluene was determined as a guest molecule by SCXRD. Interactions between γ-cyclodextrin and solvent molecules in ε-phase were evaluated using Hirshfeld surface analysis. The thermal stability of the new crystal forms of γ-CD-MOF-1 was analyzed by differential scanning calorimetry and thermogravimetric analysis.
Six novel cyclodextrin (CD)-based metal-organic frameworks (MOFs) were synthesized using distinct crystallization methodologies. A modified vapor diffusion method is introduced for the first time, termed fast crystallization, which enables the rapid solid-state formation of MOF compounds. This innovative method yielded four of the newly synthesized MOFs. The crystal structures of five obtained frameworks were structurally characterized through single-crystal X-ray diffraction, while one, compound 5 (γ-CD-K-5), was additionally characterized as a bulk powder. Structural analysis revealed that two of the newly obtained MOFs, namely, compound 2 (α-CD-K-2) and compound 3 (α-CD-Rb-3), exhibited isostructural characteristics, forming a three-dimensional (3D) framework. Compound 1 (α-CD-K-1) shared the same space group as EVEGET (α-CD-K) and displayed the same framework type. Furthermore, the crystal packing of compound 4 (β-CD-K-4) closely resembled that of compound 1 and EVEGET, with the only distinction lying in the type of CD employed. Notably, compound 6 (γ-CD-K-6) incorporated an iodine ion with an occupancy of 0.2. To discern the intermolecular interactions within the obtained MOFs, the Hirshfeld surface was calculated using Crystal Explorer software.
All four known xylazine hydrochloride polymorphous forms were obtained and their relative stabilities were compared directly at three different temperatures. At higher temperatures, it is possible to determine the relative stability of all forms directly by measuring the changes in the composition of the mixtures of two polymorphous forms using powder x-ray diffraction methods. At lower temperatures, a solvent was added to the mixture and the changes in composition were determined. Polymorph transition temperatures were determined directly. To predict the transition temperature which was not found using the direct method, the polymorph melting data and determined transition temperatures were used. A phase stability diagram was constructed from the acquired data. The stability of all anhydrous polymorphous forms was compared in the presence of water vapor pressure that was higher than the equilibrium pressure.
1 July 2014 in International Journal of Pharmaceutics